Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Cap	28	20	17	9	27	138
Market Cap Growth	233.36%	12.21%	97.57%	-66.84%	-80.67%	-22.92%
Enterprise Value	20.41	10.43	12.56	2.2	25.45	112.86
Last Close Price	2.64	2.18	2.92	1.60	13.80	100.20
PE Ratio	-	-1.01	-1.02	-0.31	-0.19	-1.44
PS Ratio	0.45	0.29	0.27	0.08	0.28	2.10
PB Ratio	2.00	1.03	0.63	0.22	0.60	1.00
P/TBV Ratio	2.07	0.72	0.58	0.14	0.46	0.61
P/FCF Ratio	-	-9.04	-10.16	-1.72	-0.92	-5.30
P/OCF Ratio	-	-10.10	-12.56	-1.72	-0.92	-5.30
EV/Sales Ratio	0.33	0.16	0.19	0.02	0.26	1.72
EV/EBITDA Ratio	5.07	-4.26	2.45	-0.27	-0.26	-2.27
EV/EBIT Ratio	-	-1.33	-7.90	-0.13	-0.23	-1.92
EV/FCF Ratio	-	-4.82	-7.32	-0.43	-0.88	-4.35
Debt / Equity Ratio	1.47	1.15	0.55	0.42	0.41	0.18
Debt / EBITDA Ratio	-3.68	-8.90	2.95	-1.98	-0.18	-0.50
Debt / FCF Ratio	-29.99	-10.08	-8.81	-3.19	-0.63	-0.95
Net Debt / Equity Ratio	-0.64	-0.48	-0.18	-0.17	-0.03	-0.18
Net Debt / EBITDA Ratio	1.60	3.73	-0.95	0.80	0.01	0.50
Net Debt / FCF Ratio	13.03	4.22	2.84	1.29	0.04	0.96
Asset Turnover	0.53	0.55	0.51	0.78	0.48	0.31
Inventory Turnover	2.10	1.74	1.34	3.57	3.27	2.77
Quick Ratio	0.93	0.98	0.70	0.75	0.64	0.71
Current Ratio	1.16	1.26	0.99	1.03	0.93	0.96
Return on Equity (ROE)	-109.23%	-60.76%	-37.33%	-40.76%	-119.62%	-50.12%
Return on Assets (ROA)	-7.19%	-6.26%	-0.99%	-12.45%	-54.45%	-28.23%
Return on Invested Capital (ROIC)	-20.81%	-16.11%	-2.46%	-29.35%	-108.38%	-53.48%
Return on Capital Employed (ROCE)	-15.98%	-13.38%	-2.58%	-24.27%	-95.82%	-41.94%
Earnings Yield	-86.26%	-99.08%	-97.95%	-319.38%	-536.30%	-69.46%
FCF Yield	-2.46%	-11.06%	-9.85%	-58.10%	-108.28%	-18.85%
Buyback Yield / Dilution	-53.18%	-75.83%	-19.88%	-176.44%	-43.93%	-29.15%

Updated Feb 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q